Kymera Therapeutics Statistics
Total Valuation
KYMR has a market cap or net worth of $8.51 billion. The enterprise value is $7.04 billion.
| Market Cap | 8.51B |
| Enterprise Value | 7.04B |
Important Dates
The next confirmed earnings date is Wednesday, August 5, 2026, before market open.
| Earnings Date | Aug 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
KYMR has 82.26 million shares outstanding. The number of shares has increased by 14.80% in one year.
| Current Share Class | 82.26M |
| Shares Outstanding | 82.26M |
| Shares Change (YoY) | +14.80% |
| Shares Change (QoQ) | +8.47% |
| Owned by Insiders (%) | 1.16% |
| Owned by Institutions (%) | 94.24% |
| Float | 65.16M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 165.23 |
| Forward PS | 135.95 |
| PB Ratio | 5.52 |
| P/TBV Ratio | 5.52 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 136.77 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.81, with a Debt / Equity ratio of 0.05.
| Current Ratio | 10.81 |
| Quick Ratio | 10.39 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1,000.36 |
Financial Efficiency
Return on equity (ROE) is -27.09% and return on invested capital (ROIC) is -17.82%.
| Return on Equity (ROE) | -27.09% |
| Return on Assets (ROA) | -17.16% |
| Return on Invested Capital (ROIC) | -17.82% |
| Return on Capital Employed (ROCE) | -22.36% |
| Weighted Average Cost of Capital (WACC) | 14.87% |
| Revenue Per Employee | $203,462 |
| Profits Per Employee | -$1.25M |
| Employee Count | 253 |
| Asset Turnover | 0.04 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +134.63% in the last 52 weeks. The beta is 1.96, so KYMR's price volatility has been higher than the market average.
| Beta (5Y) | 1.96 |
| 52-Week Price Change | +134.63% |
| 50-Day Moving Average | 98.06 |
| 200-Day Moving Average | 82.17 |
| Relative Strength Index (RSI) | 44.54 |
| Average Volume (20 Days) | 593,353 |
Short Selling Information
The latest short interest is 9.90 million, so 12.04% of the outstanding shares have been sold short.
| Short Interest | 9.90M |
| Short Previous Month | 10.15M |
| Short % of Shares Out | 12.04% |
| Short % of Float | 15.19% |
| Short Ratio (days to cover) | 7.75 |
Income Statement
In the last 12 months, KYMR had revenue of $51.48 million and -$315.00 million in losses. Loss per share was -$3.55.
| Revenue | 51.48M |
| Gross Profit | -283.00M |
| Operating Income | -355.27M |
| Pretax Income | -315.00M |
| Net Income | -315.00M |
| EBITDA | -350.84M |
| EBIT | -359.13M |
| Loss Per Share | -$3.55 |
Balance Sheet
The company has $650.93 million in cash and $80.47 million in debt, with a net cash position of $1.47 billion or $17.81 per share.
| Cash & Cash Equivalents | 650.93M |
| Total Debt | 80.47M |
| Net Cash | 1.47B |
| Net Cash Per Share | $17.81 |
| Equity (Book Value) | 1.54B |
| Book Value Per Share | 18.73 |
| Working Capital | 614.79M |
Cash Flow
In the last 12 months, operating cash flow was -$242.58 million and capital expenditures -$1.42 million, giving a free cash flow of -$244.00 million.
| Operating Cash Flow | -242.58M |
| Capital Expenditures | -1.42M |
| Depreciation & Amortization | 6.69M |
| Net Borrowing | -1.64M |
| Free Cash Flow | -244.00M |
| FCF Per Share | -$2.97 |
Margins
| Gross Margin | n/a |
| Operating Margin | -690.17% |
| Pretax Margin | -611.94% |
| Profit Margin | n/a |
| EBITDA Margin | -681.58% |
| EBIT Margin | -697.67% |
| FCF Margin | n/a |
Dividends & Yields
KYMR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -14.80% |
| Shareholder Yield | -14.80% |
| Earnings Yield | -3.70% |
| FCF Yield | -2.87% |
Analyst Forecast
The average price target for KYMR is $127.18, which is 23.00% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $127.18 |
| Price Target Difference | 23.00% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 24 |
| Revenue Growth Forecast (3Y) | -0.36% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
KYMR has an Altman Z-Score of 18.29 and a Piotroski F-Score of 2.
| Altman Z-Score | 18.29 |
| Piotroski F-Score | 2 |